Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: A randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery

✍ Scribed by David M. Ansley; Koen Raedschelders; David D.Y. Chen; Peter T. Choi

• Book ID: 116350808
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 249 KB
• Volume: 30
• Category: Article
• ISSN: 1551-7144
• DOI: 10.1016/j.cct.2009.03.004